Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Literature DB >> 1120218

I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

G R Catto, M MacLeod, B Pelc, E Kodicek.

Abstract

Three patients with chronic renal failure on maintenance haemodialysis have been treated with 1 alpha-hydroxycholecalciferol (1 alpha-OHCC), a synthetic vitamin D analogue. A daily dose of 2 mug by mouth produced a significant increase in both calcium absorption from the gastrointestinal tract and calcium content of bone. Treatment with 1 alpha-OHCC appears to be effective in cases of metabolic bone disease associated with chronic renal failure.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1975 PMID： 1120218 PMCID： PMC1671878 DOI： 10.1136/bmj.1.5948.12-a

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

23 in total

1. NEUTRON-ACTIVATION ANALYSIS IN MAN IN VIVO. A NEW TECHNIQUE IN MEDICAL INVESTIGATION.

Authors: J ANDERSON; S B OSBORN; R W TOMLINSON; D NEWTON; J RUNDO; L SALMON; J W SMITH
Journal: Lancet Date: 1964-12-05 Impact factor: 79.321

2. BONE DISEASE IN CHRONIC RENAL FAILURE.

Authors: R F FLETCHER; J H JONES; D B MORGAN
Journal: Q J Med Date: 1963-10

3. A modified bone-biopsy drill for outpatient use.

Authors: J A WILLIAMS; G I NICHOLSON
Journal: Lancet Date: 1963-06-29 Impact factor: 79.321

4. The treatment of renal-glomerular osteodystrophy.

Authors: C E DENT; C M HARPER; G R PHILPOT
Journal: Q J Med Date: 1961-01

5. Azotaemic renal osteodystrophy.

Authors: S W STANBURY
Journal: Br Med Bull Date: 1957-01 Impact factor: 4.291

Review 6. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.

Authors: H F DeLuca
Journal: N Engl J Med Date: 1973-08-16 Impact factor: 91.245

7. Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections.

Authors: E J Tripp; E H MacKay
Journal: Stain Technol Date: 1972-05

8. Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease.

Authors: G R Catto; J A McIntosh; M Macleod
Journal: Phys Med Biol Date: 1973-07 Impact factor: 3.609

9. Comparison of the stannous chloride and vanadate methods for estimation of serum inorganic phosphorus by use of the "SMA 12-60".

Authors: J L Davies; G S Andrews; R Miller; H G Owen
Journal: Clin Chem Date: 1973-04 Impact factor: 8.327

5. Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog.

Authors: M R Walters; W Hunziker; J E Bishop; A W Norman
Journal: Calcif Tissue Int Date: 1983-05 Impact factor: 4.333

Review 6. Renal bone disease.

Authors: G R Catto
Journal: J R Coll Physicians Lond Date: 1976-10

6 in total